This inventor holds 3 USPTO granted patents. Top assignee: Genentech, Inc.. Active years: 2003-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2004
Title: The Innovations of Frederic DeSauvage
Introduction
Frederic DeSauvage is a notable inventor based in Foster City, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides and nucleic acids. With a total of 3 patents to his name, DeSauvage continues to push the boundaries of scientific innovation.
Latest Patents
One of his latest patents is focused on chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same. This invention is directed towards novel chimpanzee erythropoietin polypeptides and the nucleic acid molecules that encode these polypeptides. Additionally, the patent includes vectors and host cells that comprise these nucleic acid sequences, as well as chimeric polypeptide molecules that fuse the polypeptides of the present invention with heterologous polypeptide sequences. Antibodies that bind to these polypeptides are also provided in this patent.
Another significant patent by DeSauvage involves OB protein-polymer chimeras. This invention concerns long-half derivatives of the obesity protein OB. Specifically, it addresses OB protein-immunoglobulin chimeras and polyethylene glycol (PEG)-OB derivatives, which exhibit an extended half-life compared to the corresponding native OB proteins. The invention further relates to methods for treating obesity using these long half-life derivatives of OB.
Career Highlights
Frederic DeSauvage is currently associated with Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to contribute to groundbreaking research and advancements in the field.
Collaborations
Throughout his career, DeSauvage has collaborated with esteemed colleagues, including Dennis J Henner and Nancy Levin. These collaborations have fostered an environment of innovation and creativity, leading to significant advancements in their respective fields.
Conclusion
Frederic DeSauvage's contributions to biotechnology through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to impact the scientific community and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile